⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 1, 2023Hepatology

Prevalence, distribution, and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings

Chul‐min Lee Eileen L. Yoon Mimi Kim Bo-Kyeong Kang Seon Cho Eun‐Hee Nah Dae Won Jun

View at Publisher

Ask AI

Bookmark

Share

Abstract

Almost all the patients with NAFLD met the new criteria for MASLD. The fibrosis burden of the MetALD group was higher than those of the MASLD and ALD groups.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lee et al. (2023) studied this question.

synapsesocial.com/papers/69d76df7aa68b335b4f316ce https://doi.org/10.1097/hep.0000000000000664

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1From NAFLD to MAFLD: Implications of a Premature Change in TerminologyOriginal Research · 2020 · 417 citations
2Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosisCross-Sectional Study · 2017 · 375 citations
3Hepatic Steatosis: Quantification by Proton Density Fat Fraction with MR Imaging versus Liver BiopsyRetrospective Study · 2013 · 394 citations
4Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment with MR ElastographyRetrospective Study · 2013 · 231 citations
5Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortalityOriginal Research · 2022 · 69 citations

More related papers

Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta‐analysis2022
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡2006
The NAFLD fibrosis score2007

More from Hepatology

Baveno VI criteria validation and development of a new non-invasive strategy for varices rule-out in patients with HCC (SAPHE-R: Stiffness, ALBI, Platelets, HEpatocellular carcinoma Rule)Thu,
AASLD AGA clinical Practice Guideline on management of primary biliary cholangitisThu,